Medical Device News Magazine

ACC Middle East 2022 Together with 13th Emirates Cardiac Society Congress to Highlight Emerging Trends, Contemp

The American College of Cardiology

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The American College of Cardiology and Emirates Cardiac Society will host ACC Middle East 2022 Together with 13th Emirates Cardiac Society Congress in Dubai, United Arab Emirates, from October 7-9, 2022.

The annual conference will bring together cardiac care teams in the Middle East region with global cardiovascular experts to examine emerging trends, evidence-based strategies and contemporary best practices for the prevention and management of cardiovascular disease.

“The annual Emirates Cardiac Society congress is one of the biggest meetings in the region. This year we are proud to partner with the ACC for the third time to produce a state-of-the-art conference,” said Wael A. Almahmeed, MD, FACC, UAE Vice Chair of the conference and a consultant cardiologist at the Heart and Vascular Institute at Cleveland Clinic Abu Dhabi. “We have five tracks covering all the subspecialties of cardiology and including the latest in late-breaking science.”

Khaled M. Ziada, MD, FACC, and Wael A. Almahmeed, MD, FACC, will serve as Vice Chairs for the conference. Valentin Fuster, MD, PhD, MACC, editor-in-chief of the Journal of the American College of Cardiology, will present the Opening Plenary Session, “Role of Imagenomics in Enhancing Cardiovascular Health Throughout the Lifespan.” Other plenaries will focus on the following key topics:

  • Top Takeaways From the Latest Guidelines: Chest Pain and Coronary Revascularization
  • The Highlights of the 2022 ACC/AHA/HFSA Guidelines For Management of Heart Failure
  • Lipid Lowering Therapy Beyond Statins
  • Artificial Intelligence in Cardiology

All attendees will have access to the interactive learning lab, featuring a hands-on echo simulation, challenging clinical case discussions, Heart Songs 5, ECG Drill & Practice, and more.

Contact Katie Glenn at to receive embargoed copies of the abstracts or apply for media credentials. All posters are embargoed until Monday, October 3, 2022, at 12 a.m. ET/8 a.m. Gulf Standard Time. Below is a selection of posters being presented at the conference:

  • Ivabradine effects on COVID-19 induced postural orthostatic tachycardia syndrome
  • Do Middle Eastern Women with Atrial Fibrillation Have Worse Baseline Clinical Profiles and One-Year Cardiovascular [Events] Compared with Men? The Jordan Atrial Fibrillation Study
  • Impact of the Morning vs. Evening Dosing of Antihypertensive Drugs on 24 Hour Ambulatory Blood Pressure
  • The effect of lavender aromatherapy on anxiety reduction in cardiovascular patients: a systematic review and meta-analysis of randomized controlled trials
  • Association of grain intake and premature coronary artery disease: Iranian Premature Coronary Artery Disease Study

To learn more about the conference visit

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.

ArisGlobal Reports | Newest Version of LifeSphere® Regulatory Platform Launches

Ann-Marie Orange, CIO & Global Head of R&D shares, “With more than 35 years of experience in life sciences technology, ArisGlobal is the only technology company offering strong Safety, Regulatory, and Quality Management solutions powered with next-generation cognitive computing, delivering unmatched interoperability across the R&D IT ecosystem. Over the last 18 months ArisGlobal has made significant investment in the strategic acquisitions of Amplexor Life Sciences and SPORIFY, along with technology R&D – and we’re not stopping.”